Kurata Lance 4
4 · Arcturus Therapeutics Holdings Inc. · Filed Dec 22, 2020
Insider Transaction Report
Form 4
Kurata Lance
Chief Legal Officer
Transactions
- Award
Stock Option (right to buy)
2020-12-18+25,000→ 25,000 totalExercise: $99.29Exp: 2030-12-18→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying the option vest on the one year anniversary of the date of grant, with the remainder vesting in 36 successive equal monthly increments thereafter.